Please login to the form below

Not currently logged in
Email:
Password:

Dice

This page shows the latest Dice news and features for those working in and with pharma, biotech and healthcare.

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Sanofi has made a small-molecule discovery engine developed by US biotech DiCE Molecules a core part of its R&D portfolio. ... The French pharma group has signed an agreement with two-year-old DiCE to find drugs for a dozen disease targets over the next

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    In pharmaceuticals, Sanofi's deal with DiCE topped the Deal Watch chart with a headline value of $2.3bn. ... Acquisition – division. $5, 869. DiCE Molecules/ Sanofi. Technology platform to select and optimise drug-like ligands targeting a range of

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics